Your SlideShare is downloading. ×
Horizon 2020 - Alain Thielemans
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Horizon 2020 - Alain Thielemans

534
views

Published on

Workshop subsidiekanalen voor ouderenzorg - 23/04/2014

Workshop subsidiekanalen voor ouderenzorg - 23/04/2014

Published in: Healthcare, Technology, Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
534
On Slideshare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
10
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. 1 Horizon 2020 Alain Thielemans, IWT
  • 2. Horizon 2020 and SC 1: Health, demographic change and well being Work programme 2014-2015 European Commission DG Research and Innovation Thematische infosessie Horizon 2020 Life sciences
  • 3. Horizon 2020 - what's new? • A single programme bringing together three separate programmes/initiatives* • Coupling research to innovation – from research to retail, all forms of innovation • Focus on societal challenges facing European society e.g. health and ageing, clean energy and transport • Simplified access, for all companies, universities, institutes in all EU countries and beyond ⃰The 7th Research Framework Programme (FP7), innovation aspects of Competitiveness and Innovation Framework Programme (CIP), EU contribution to the European Institute of Innovation and Technology (EIT)
  • 4. More opportunities for SMEs • Integrated approach - 20% of the total budget for societal challenges and LEITs to go to SMEs • Simplification of particular benefit to SMEs (e.g. single entry point) • A new SME instrument • 'Access to risk finance' will have a strong SME focus (debt and equity facility)
  • 5. Less prescriptive topic texts Two-year work programme Stronger focus on end users Broad topics Challenge-driven A new approach
  • 6. Three priorities Excellent science Industrial leadership Societal challenges
  • 7. Recap: the 'Health, demographic change and wellbeing' challenge Proposed funding 2014-2020 (million EUR)
  • 8. Strategic Initiatives Innovative Medicines Initiative 2 www.imi.europa.eu European & Developing Countries Clinical Trials Partnership (EDCTP2) www.edctp.org Active and Assisted Living 2 www.aal-europe.eu European Innovation Partnership on Active and Healthy Ageing https://webgate.ec.europa.eu/eipaha
  • 9. The Work Programme 2014/15 in brief Call for 'co-ordination activities' 15 topics (10 in 2014, 5 in 2015) Call 'personalising health and care' 34 topics (15 in 2014, 17 in 2015, 2 open in both years) € 1,21 billion
  • 10. Personalising Health and Care
  • 11. Advancing active and healthy ageing Integrated, sustainable, citizen-centred care Improving health information, data exploitation and providing an evidence base for health policies and regulation Innovative treatments and technologies Improving diagnosis 7 Focus Areas Effective health promotion, disease prevention, preparedness and screening Understanding health, ageing & disease
  • 12. Understanding the call topics: example 'PHC 2 – 2015' 'Specific challenge' 'Scope' 'Expected impact' 'Type of action'
  • 13. • Therapies for non-communicable diseases (2014) (PHC 13) and rare diseases (2015) (PHC 14) • Clinical research on regenerative medicine (2014) (PHC15) • Tools and technologies for advanced therapies (2015) (PHC 16) • Comparing and establishing effectiveness of health interventions in the elderly (2014) (PHC 17) and in paediatric population (2015) (PHC 18) Finding the cure … and evaluating existing treatments
  • 14. • Service robotics within assisted living environments (2014) (PHC 19*) • Pilot projects on independent living with cognitive impairments (2014) (PHC 20*) (Innovation type of action) • Early risk detection and intervention (2015) (PHC 21*) Adding more life to our years * Topics with ICT focus
  • 15. • Self-management of health and disease: • citizen engagement and mHealth for disease management (2014), (PHC 26*) • patient empowerment supported by ICT (2015) (PHC 27*) • based on predictive computer modelling (2015) (PHC28*) • Public procurement of innovative eHealth services (2015) (PHC 29*) • ICT systems for integrated care (2015) (PHC 25*) • eHealth sectorial inducement prize (2015) The citizen in the centre * Topics with ICT focus
  • 16. Applying for funding: how does it work? Horizon 2020 'Health, demographic change and wellbeing' Horizon 2020 'Health, demographic change and wellbeing' Rome, 3 December 2013
  • 17. Conditions for Participation Minimum conditions  Standard collaborative actions At least three legal entities each established in a different Member State or an Associated Country;  ERC, SME instrument, programme co-fund, coordination and support, training and mobility actions: One legal entity established in a Member State or in an Associated Country. Additional Conditions  In the work programme or work plan. No additional conditions in Health WP except for SME instrument
  • 18. One project = One rate  For all beneficiaries and all activities in the grant.  Defined in the Work Programme: (*) Research and technological development includes scientific coordination. (**) For beneficiaries that are non-profit public bodies, secondary and higher education establishments, research organisations and SMEs (***) The reimbursement of indirect eligible costs, in the case of coordination and support actions, may reach a maximum 7% of the direct eligible costs, excluding the direct eligible costs for subcontracting and the costs of resources made available by third parties which are not used on the premises of the beneficiary. (****) Including research for the benefit of specific groups (in particular SMEs) Maximum reimburseme nt rates Research and technological development activities (*) Demonstrati on activities Other activities Network of excellence 50% 75% (**) 100% Collaborative project(****) 50% 75% (**) 50% 100% Coordination and support action 100% (***) A single funding rate FP7 Horizon 2020 Single indirect cost model: 25 % Flat Rate
  • 19. Time to grant: speeding up the process - I A maximum TTG of 8 months 5 months for informing all applicants on scientific evaluation 3 months for signature of GA
  • 20. Time to grant: speeding up the process - II How to speed up the process  No detailed negotiations: each proposal evaluated 'as it is', not as 'what could be';  Legal entity validated in parallel.  No more paper: e-communication & e-signature of grants.
  • 21. Evaluation criteria 1. Excellence  Ground-breaking nature (e.g. level of ambition, beyond the state-of-the-art, novel approach, addresses challenge, … )  Conceptually robust; trans-disciplinarity considered… 2. Impact […] extent to which project outputs contribute to:  The expected impacts listed in the work programme under the relevant topic;  Enhancing innovation capacity and integration of new knowledge;  Strengthening the competitiveness and growth of companies by developing innovations meeting the needs of European and global markets;  Effectiveness of the proposed measures to communicate the project, disseminate and/or exploit the project results, and appropriate management of IPR. 3. Quality and efficiency of implementation  Coherence and effectiveness of the work plan, including appropriateness of the allocation of tasks and resources;  Competences, experience and complementarity of the individual participants, as well as of the consortium as a whole;  Appropriateness of the management structures and procedures, including risk management
  • 22. Scoring/weights/thresholds As in FP7 each criterion scored out of 5; thresholds will be applied for each criterion and the total score, different depending on the call and action Unlike FP7, for Innovation Actions and SME instrument…  impact criterion weighted by factor of 1.5  Impact considered first when scores equal
  • 23. More information: Contact your National Contact Point for H2020 Health Alain Deleener (IWT) E-mail: adl@iwt.be Tel: 02/ 432 42 39
  • 24. HORIZON 2020 Thank you for your attention! Find out more: www.ec.europa/research/horizon2020